Pure Global

Efficacy and safety study of PAXMAN and HairRepro MEDI Alpha for Chemotherapy Induced Alopecia for breast cancer - Trial UMIN000048637

Access comprehensive clinical trial information for UMIN000048637 through Pure Global AI's free database. This Not Applicable trial is sponsored by Department of Surgery and Science, Faculty of Medicine,Academic Assembly, University of Toyama and is currently Recruiting. The study focuses on breast cancer.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to University Hospital Medical Information Network data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
Device Trial
UMIN000048637
Not Applicable
Recruiting
Device Trial
device
Trial Details
University Hospital Medical Information Network โ€ข UMIN000048637
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Efficacy and safety study of PAXMAN and HairRepro MEDI Alpha for Chemotherapy Induced Alopecia for breast cancer

Study Focus

breast cancer

Interventional

device

Sponsor & Location

Department of Surgery and Science, Faculty of Medicine,Academic Assembly, University of Toyama

Japan

Timeline & Enrollment

Not Applicable

Aug 15, 2022

N/A

ICD-10 Classifications

Malignant neoplasm of breast
Malignant neoplasm of breast
Carcinoma in situ of breast, unspecified
Malignant neoplasm: Breast, unspecified
Other carcinoma in situ of breast

Data Source

University Hospital Medical Information Network

UMIN000048637

Device Trial